# Minocycline to Treat Amyotrophic Lateral Sclerosis

> **NCT00047723** · PHASE3 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 400 (—)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** minocycline

## Key facts

- **NCT ID:** NCT00047723
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 400 (—)
- **Last updated:** 2007-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047723, "Minocycline to Treat Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00047723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*